Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1954 1
1955 1
1956 1
1961 5
1962 5
1963 10
1964 3
1965 4
1966 2
1967 8
1968 8
1969 5
1970 5
1971 6
1972 6
1973 7
1974 10
1975 4
1976 7
1977 9
1978 9
1979 17
1980 11
1981 13
1982 10
1983 14
1984 22
1985 33
1986 24
1987 41
1988 38
1989 41
1990 45
1991 34
1992 48
1993 40
1994 49
1995 72
1996 74
1997 75
1998 94
1999 75
2000 115
2001 94
2002 75
2003 79
2004 77
2005 88
2006 104
2007 100
2008 83
2009 77
2010 104
2011 116
2012 132
2013 166
2014 124
2015 116
2016 115
2017 117
2018 123
2019 145
2020 167
2021 191
2022 116
Text availability
Article attribute
Article type
Publication date

Search Results

3,316 results
Results by year
Filters applied: . Clear all
Page 1
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y; TACTICS study group. Kudo M, et al. Among authors: wada y. Gut. 2020 Aug;69(8):1492-1501. doi: 10.1136/gutjnl-2019-318934. Epub 2019 Dec 4. Gut. 2020. PMID: 31801872 Free PMC article. Clinical Trial.
High-Throughput Reclassification of SCN5A Variants.
Glazer AM, Wada Y, Li B, Muhammad A, Kalash OR, O'Neill MJ, Shields T, Hall L, Short L, Blair MA, Kroncke BM, Capra JA, Roden DM. Glazer AM, et al. Among authors: wada y. Am J Hum Genet. 2020 Jul 2;107(1):111-123. doi: 10.1016/j.ajhg.2020.05.015. Epub 2020 Jun 12. Am J Hum Genet. 2020. PMID: 32533946 Free PMC article.
Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients.
Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, Inai C, Iwasaki Y, Kumano M, Murakami Y, Omodaka K, Abe T, Komori S, Gao D, Hirakata T, Kurata K, Hosono K, Ueno S, Hotta Y, Murakami A, Terasaki H, Wada Y, Nakazawa T, Ishibashi T, Ikeda Y, Kubo M, Sonoda KH. Koyanagi Y, et al. Among authors: wada y. J Med Genet. 2019 Oct;56(10):662-670. doi: 10.1136/jmedgenet-2018-105691. Epub 2019 Jun 17. J Med Genet. 2019. PMID: 31213501
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.
Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, Takita M, Hagiwara S, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Nishida N. Kudo M, et al. Among authors: wada y. Cancers (Basel). 2019 Jul 31;11(8):1084. doi: 10.3390/cancers11081084. Cancers (Basel). 2019. PMID: 31370183 Free PMC article.
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
Yamashita T, Kudo M, Ikeda K, Izumi N, Tateishi R, Ikeda M, Aikata H, Kawaguchi Y, Wada Y, Numata K, Inaba Y, Kuromatsu R, Kobayashi M, Okusaka T, Tamai T, Kitamura C, Saito K, Haruna K, Okita K, Kumada H. Yamashita T, et al. Among authors: wada y. J Gastroenterol. 2020 Jan;55(1):113-122. doi: 10.1007/s00535-019-01642-1. Epub 2019 Nov 12. J Gastroenterol. 2020. PMID: 31720835 Free PMC article. Clinical Trial.
Reply.
Wada Y, Zhu Z, Goel A. Wada Y, et al. Gastroenterology. 2022 Jan;162(1):348-349. doi: 10.1053/j.gastro.2021.09.013. Epub 2021 Sep 14. Gastroenterology. 2022. PMID: 34529991 No abstract available.
Craniotabès chez un nouveau-né.
Wada Y, Kubo K, Tsubata S. Wada Y, et al. CMAJ. 2020 Dec 7;192(49):E1784. doi: 10.1503/cmaj.200192-f. CMAJ. 2020. PMID: 33288518 Free PMC article. French. No abstract available.
3,316 results